rufinamide has been researched along with zonisamide in 4 studies
| Studies (rufinamide) | Trials (rufinamide) | Recent Studies (post-2010) (rufinamide) | Studies (zonisamide) | Trials (zonisamide) | Recent Studies (post-2010) (zonisamide) |
|---|---|---|---|---|---|
| 175 | 22 | 118 | 922 | 121 | 382 |
| Protein | Taxonomy | rufinamide (IC50) | zonisamide (IC50) |
|---|---|---|---|
| Carbonic anhydrase 12 | Homo sapiens (human) | 1.86 | |
| Carbonic anhydrase 1 | Homo sapiens (human) | 1.86 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 1.86 | |
| Carbonic anhydrase 2 | Bos taurus (cattle) | 1.86 | |
| Carbonic anhydrase 3 | Homo sapiens (human) | 1.86 | |
| Carbonic anhydrase 4 | Homo sapiens (human) | 1.86 | |
| Carbonic anhydrase 6 | Homo sapiens (human) | 1.86 | |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | 1.86 | |
| Carbonic anhydrase 7 | Homo sapiens (human) | 1.86 | |
| Carbonic anhydrase 9 | Homo sapiens (human) | 1.86 | |
| Carbonic anhydrase 13 | Homo sapiens (human) | 1.86 | |
| Carbonic anhydrase 14 | Homo sapiens (human) | 1.86 | |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | 1.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Albani, F; Baruzzi, A; Candela, C; Contin, M; Mohamed, S; Riva, R | 1 |
| Baum, L; Chan, PS; Kwan, P; Zhang, C; Zuo, Z | 1 |
| Arslan, EA; Cansu, A; Dilber, B; Esenülkü, G; Gürgen, SG; Kamaşak, T; Kart, PÖ; Şahin, S; Sarsmaz, HY; Topsakal, AS; Yazar, U; Yıldız, N | 1 |
1 review(s) available for rufinamide and zonisamide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for rufinamide and zonisamide
| Article | Year |
|---|---|
Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Felbamate; Humans; Isoxazoles; Lamotrigine; Oxcarbazepine; Phenylcarbamates; Propylene Glycols; Triazines; Triazoles; Ultraviolet Rays; Zonisamide | 2010 |
In vitro transport assays of rufinamide, pregabalin, and zonisamide by human P-glycoprotein.
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line, Transformed; Dogs; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Gene Expression; Humans; Isoxazoles; Pregabalin; Rhodamine 123; Swine; Transfection; Triazoles; Zonisamide | 2014 |
An investigation of the effects of chronic zonisamide, sultiam, lacosamide, clobazam, and rufinamide anti-seizure medications on foliculogenesis in ovarian tissue in prepubertal non-epileptic rats.
Topics: Animals; Clobazam; Female; Lacosamide; Rats; Rats, Wistar; Thiazines; Triazoles; Zonisamide | 2022 |